Nisa Investment Advisors, LLC Karyopharm Therapeutics Inc. Transaction History

Nisa Investment Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$0.87 - $1.58 $132 - $240	-152 Reduced 75.25%	50 $0
Q1 2024 May 01, 2024	BUY	$0.72 - $1.66 $145 - $335	202 New	202 $0
Q2 2023 Aug 11, 2023	SELL	$1.79 - $4.59 $107 - $275	-60 Reduced 6.98%	800 $1,000
Q1 2023 May 02, 2023	BUY	$2.84 - $3.92 $170 - $235	60 Added 7.5%	860 $3,000
Q4 2022 Feb 02, 2023	SELL	$2.48 - $5.93 $12,152 - $29,057	-4,900 Reduced 85.96%	800 $3,000
Q3 2022 Nov 07, 2022	BUY	$4.08 - $5.82 $19,992 - $28,518	4,900 Added 612.5%	5,700 $26,000
Q2 2021 Aug 06, 2021	SELL	$8.11 - $11.11 $26,357 - $36,107	-3,250 Reduced 80.25%	800 $8,000
Q4 2020 Jan 25, 2021	BUY	$14.15 - $17.19 $7,782 - $9,454	550 Added 15.71%	4,050 $63,000
Q3 2020 Oct 20, 2020	BUY	$14.14 - $19.71 $37,471 - $52,231	2,650 Added 311.76%	3,500 $51,000
Q2 2020 Jul 27, 2020	BUY	$16.6 - $25.25 $4,316 - $6,565	260 Added 44.07%	850 $16,000
Q1 2020 Apr 17, 2020	BUY	$14.38 - $27.72 $8,484 - $16,354	590 New	590 $11,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.